Clinical Trial Update: Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Preserved Ejection Fraction (Cycle-2-PEF) [Phase 2]

View source ↗

Summary

The Phase 2 trial Cycle-2-PEF evaluating Tovinontrine for heart failure with preserved ejection fraction has completed, reporting on safety and effectiveness.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Heart Disease
• Heart Failure
• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• Tovinontrine (tovinontrine)

Snippet

Sponsor: Cardurion Pharmaceuticals, Inc. | Conditions: Heart Failure, Heart Failure Preserved Ejection Fraction | Phase 2 | Status: COMPLETED